Literature DB >> 9873491

The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.

D H Steinman1, M L Curtin, R B Garland, S K Davidsen, H R Heyman, J H Holms, D H Albert, T J Magoc, I B Nagy, P A Marcotte, J Li, D W Morgan, C Hutchins, J B Summers.   

Abstract

A series of succinate-derived hydroxamic acids incorporating a macrocyclic ring were designed, synthesized, and evaluated as inhibitors of matrix metalloproteinases. The inhibitors were designed based on the published X-ray crystal structure of batimastat (1) complexed with human neutrophil collagenase (MMP-8). The synthesized compounds were shown to inhibit selected MMPs in vitro with low nanomolar potency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9873491     DOI: 10.1016/s0960-894x(98)00396-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design.

Authors:  Fabián Villalta-Romero; Anna Gortat; Andrés E Herrera; Rebeca Arguedas; Javier Quesada; Robson Lopes de Melo; Juan J Calvete; Mavis Montero; Renato Murillo; Alexandra Rucavado; José María Gutiérrez; Enrique Pérez-Payá
Journal:  ACS Med Chem Lett       Date:  2012-06-14       Impact factor: 4.345

2.  Reactions of N-benzyloxycarbamate derivatives with stabilized carbon nucleophiles: a new synthetic approach to polyhydroxamic acids and other hydroxamate-containing mixed ligand systems.

Authors:  Yuan Liu; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  J Org Chem       Date:  2009-01-16       Impact factor: 4.354

Review 3.  Challenges in Matrix Metalloproteinases Inhibition.

Authors:  Helena Laronha; Inês Carpinteiro; Jaime Portugal; Ana Azul; Mário Polido; Krasimira T Petrova; Madalena Salema-Oom; Jorge Caldeira
Journal:  Biomolecules       Date:  2020-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.